ID: hypothesis-h-d78123d1
Hypothesis
Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery
Genetically modified microglia overexpressing mitochondrial export machinery package healthy mitochondria into extracellular vesicles with neuron-specific targeting ligands.
EvidencePending (0%)📖 15 cit🗣 3 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Genetically modified microglia overexpressing mitochondrial export machinery package healthy mitochondria into extracellular vesicles with neuron-specific targeting ligands.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
graph TD
A["Microglia"] --> B["Natural EV Secretion"]
B --> C["Extracellular Vesicles"]
D["Engineering EVs"] --> E["RAB27A Overexpression"]
E --> F["Enhanced EV Production"]
D --> G["LAMP2B Surface Targeting"]
G --> H["Neuron-Specific Ligands"]
H --> I["Targeted EV Delivery"]
D --> J["Load Healthy Mitochondria"]
J --> K["Mito-Enriched EVs"]
F --> L["Engineered Microglia-EVs"]
I --> L
K --> L
L --> M["Targeted Delivery to Damaged Neurons"]
N["Damaged Neurons"] --> O["Mitochondrial Dysfunction"]
O --> P["Energy Failure"]
M --> Q["Mito Integration into Neurons"]
Q --> R["Restored Bioenergetics"]
R --> S["Neuronal Rescue"]
T["Advantages"] --> U["Cross BBB via EVs"]
T --> V["Cell-Type-Specific Targeting"]
T --> W["Scalable Production"]
S --> X["Targeted Mitochondrial Therapy"]
style A fill:#264653,stroke:#ffd54f,color:#e0e0e0
style D fill:#1a3a4a,stroke:#4fc3f7,color:#e0e0e0
style M fill:#1a3a2a,stroke:#81c784,color:#e0e0e0
style X fill:#2a3a1a,stroke:#c5e1a5,color:#e0e0e0⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Supports
Microglia release mitochondria-containing extracellular vesicles that can rescue neuronal function
Contradicts
Most mitochondria-containing extracellular vesicles actually contain mitochondrial fragments or DNA, not intact functional organelles
Contradicts
Systemically delivered LAMP2B-targeted vesicles show <1% brain uptake and poor neuronal specificity
Contradicts
Microglial activation states critically determine vesicle content, with pro-inflammatory microglia releasing damaging rather than protective cargo
📖 Linked Papers (15)Export BibTeX ↗
Adapting Drosophila melanogaster Cell Lines to Serum-Free Culture Conditions.
G3 (Bethesda, Md.) (2020) · PubMed:33028628 ↗
5 figures

Figure 1
Adapting Drosophila S2R+ cells to FEx supplemented media. S2R+ cells were gradually adapted from M3 + BPYE + 10% FBS (MB10) into M3 + 10% FEx and M3 + 2.5% FE...

Figure 3
Differential gene expression in S2R+ cultures across three culture conditions. (A) Volcano plot of differentially expressed genes from comparison of cells cultu...
Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
British journal of cancer (2019) · PubMed:31591459 ↗
1 figure
Figures
Figures available at source paper (no open-access XML found).
Predictive Role of High Blood Pressure for the Incidence of Metabolic Syndrome.
Cardiology (2019) · PubMed:31261156 ↗
1 figure
Figures
Figures available at source paper (no open-access XML found).
Brain Photobiomodulation Therapy: a Narrative Review.
Molecular neurobiology (2018) · PubMed:29327206 ↗
1 figure
Figures
Figures available at source paper (no open-access XML found).
Angiopep-2-engineered extracellular vesicles derived from spinal cord injury-responsive brown adipose tissue for targeted neuroinflammation modulation.
Journal of nanobiotechnology (2026) · PubMed:41787360 ↗
No figures
Engineering integrin αvβ8-targeted extracellular vesicles to deliver BDNF mRNA for motor recovery in spinal cord injury.
Journal of nanobiotechnology (2026) · PubMed:41749221 ↗
No figures
Engineered Biomimetic Nanorobots Orchestrate Targeted Nose-to-Brain Delivery to Resolve Neuron-Glia Entanglement against Parkinson's Disease.
Small (Weinheim an der Bergstrasse, Germany) (2026) · PubMed:41607240 ↗
No figures
hUC-MSC-derived exosomes ameliorate Alzheimer's disease pathology through lncRNA-9969-mediated multi-target protection involving neuronal autophagy and microglial modulation.
Alzheimer's research & therapy (2026) · PubMed:41540476 ↗
No figures
Extracellular vesicles: A new therapeutic drug for nerve injury repair.
Neural regeneration research (2025) · PubMed:41467441 ↗
No figures
Engineered extracellular vesicles-mediated curcumin delivery in brain microenvironment modulating lysosomes, mitochondria, and microglia reprogram for parkinson's disease therapy.
Journal of nanobiotechnology (2025) · PubMed:41390406 ↗
No figures
Rab27a-mediated exosome secretion in anterior cingulate cortex contributes to colorectal visceral pain in adult mice with neonatal maternal deprivation.
American journal of physiology. Gastrointestinal and liver physiology (2023) · PubMed:37529842 ↗
No figures
Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor Progression.
Frontiers in molecular biosciences (2020) · PubMed:33282910 ↗
No figures
📙 Related Wiki Pages (15)
Mitochondrial Biogenesis InducerstherapeuticSection 138: Advanced Extracellular MatrtherapeuticiPSC-Derived Neurons for Drug Screening therapeuticMitochondrial Dynamics Modulators for NetherapeuticMitochondrial Support Strategies for CBStherapeuticSection 194: Advanced Membrane TraffickitherapeuticBBB-Penetrant Antibody EngineeringtherapeuticAAV Gene Therapy for Neurodevelopmental therapeuticExosome-Based Drug Delivery for CBS/PSPtherapeuticGlial Cell Line-Derived Neurotrophic FactherapeuticRAB27A GenegeneRAB27A Protein (Ras-Related Protein Rab-proteinExtracellular Vesicle-Mediated SynucleinhypothesisAutologous Stem Cell-Derived DopaminergiclinicalExtracellular Vesicle-Based Neuroprotectidea
🏥 Translation
🧬 3D Protein Structure — RAB27A
No curated PDB or AlphaFold mapping for RAB27A yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for RAB27A/LAMP2B from GTEx v10.
💉 Clinical Trials (5)Relevance: 38%
0
Active
Active
0
Completed
Completed
1,240
Total Enrolled
Total Enrolled
PHASE1
Highest Phase
Highest Phase
UNKNOWN·NCT04887675 · University of Novi Sad
120 enrolled · 2021-05-01 · → 2022-06-01
Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
MRI
ENROLLING_BY_INVITATION·NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
310 enrolled · 2025-02-14 · → 2026-10-01
The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
RECRUITING·NCT00029965 · National Human Genome Research Institute (NHGRI)
200 enrolled · 2002-02-06
Study description:
This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
Neurological Regression Myoclonus Cherry Red Spot
COMPLETED·NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
510 enrolled · 2020-11-16 · → 2024-12-12
The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
Retinal Function Cognitive Dysfunction Microperimetry
UNKNOWN·NCT04248270 · Chang Gung Memorial Hospital
100 enrolled · 2020-02-20 · → 2023-08-17
Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
Alzheimer's Disease Vascular Dementia Dementia
18F-PM-PBB3
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for RAB27A.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
2.5 years
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
Medium
0.0497
Events (7d)
0
Price History
▲24.1%💾 Resource Usage
LLM Tokens
39,356
$0.2361
Total Cost
$0.2361
🔮 Predictions
🔎 Predictions vs Observations4 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If hypothesis is true, intervention be assessed using MitoTracker dyes and electron microscopy of isolated EVs | be assessed using MitoTracker dyes and electron microscopy of isolated EVs | — no observation — | pending | 0.30 |
| If hypothesis is true, intervention involve primary microglia or immortalized microglial cell lines (BV2, N9) transfected with lentiviral vectors expressing RAB27A and LAMP2B-RVG fusion proteins | involve primary microglia or immortalized microglial cell lines (BV2, N9) transfected with lentiviral vectors expressing RAB27A and LAMP2B-RVG fusion proteins | — no observation — | pending | 0.30 |
| If hypothesis is true, intervention restore neuronal bioenergetics in neurodegenerative conditions | restore neuronal bioenergetics in neurodegenerative conditions | — no observation — | pending | 0.30 |
| If hypothesis is true, intervention rescue bioenergetic deficits in Parkinson's disease models | rescue bioenergetic deficits in Parkinson's disease models | — no observation — | pending | 0.30 |
🔮 Falsifiable Predictions (4)
pendingconf 30%
If hypothesis is true, intervention involve primary microglia or immortalized microglial cell lines (BV2, N9) transfected with lentiviral vectors expressing RAB27A and LAMP2B-RVG fusion proteins
Predicted outcome: involve primary microglia or immortalized microglial cell lines (BV2, N9) transfected with lentiviral vectors expressing RAB27A and LAMP2B-RVG fusion
Falsification: Intervention fails to involve primary microglia or immortalized microglial cell lines (BV2, N9) transfected with lentiviral vectors expressing RAB27A and LAMP2B-RVG fusion proteins
pendingconf 30%
If hypothesis is true, intervention be assessed using MitoTracker dyes and electron microscopy of isolated EVs
Predicted outcome: be assessed using MitoTracker dyes and electron microscopy of isolated EVs
Falsification: Intervention fails to be assessed using MitoTracker dyes and electron microscopy of isolated EVs
pendingconf 30%
If hypothesis is true, intervention restore neuronal bioenergetics in neurodegenerative conditions
Predicted outcome: restore neuronal bioenergetics in neurodegenerative conditions
Falsification: Intervention fails to restore neuronal bioenergetics in neurodegenerative conditions
pendingconf 30%
If hypothesis is true, intervention rescue bioenergetic deficits in Parkinson's disease models
Predicted outcome: rescue bioenergetic deficits in Parkinson's disease models
Falsification: Intervention fails to rescue bioenergetic deficits in Parkinson's disease models
▸Metadata
| status | proposed |
| disease | neurodegeneration |
| target_gene | RAB27A/LAMP2B |
| target_pathway | None |
| _schema_version | 1 |
| composite_score | 0.43 |
📊 Evidence Profile
Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
904
Outgoing
185
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.